Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects

Fig. 1

The role of macrophages in IIMs. When tissue is damaged, inflammatory monocytes are recruited from the circulation and are converted into macrophages during migration. At the same time, resident tissue macrophages proliferate while recruiting peripheral blood immune cells, which primarily constitute the first wave of immune cell influx. Activated macrophages tend to exhibit a proinflammatory phenotype at an early stage. They can exert direct killing effects by producing ROS, NSs and proteases. In addition, macrophages secrete a variety of inflammatory mediators to drive autoimmune inflammation, and cytokines secreted by macrophages can induce the differentiation and expansion of Th1 and Th17 cells and promote the development of inflammatory responses. On the other hand, the phagocytosis of apoptotic cells by macrophages can be enhanced by Tregs. All these factors contribute to the progression of inflammation. ROS, reactive oxygen species; Treg, regulatory T cells; NS, nitrogen species; Th1 and Th17 cells, T helper cells that express IFN-γ and IL-17; IL-6, interleukin-6; IL-10, interleukin-10; IL-13, interleukin-13; IL-12, interleukin-12; IL-23, interleukin-23; TNF-α, tumor necrosis factor-α

Back to article page